DE602006013604D1 - Verfahren zur bestimmung der reaktionsfähigkeit gegenüber chk1-inhibitoren - Google Patents
Verfahren zur bestimmung der reaktionsfähigkeit gegenüber chk1-inhibitorenInfo
- Publication number
- DE602006013604D1 DE602006013604D1 DE602006013604T DE602006013604T DE602006013604D1 DE 602006013604 D1 DE602006013604 D1 DE 602006013604D1 DE 602006013604 T DE602006013604 T DE 602006013604T DE 602006013604 T DE602006013604 T DE 602006013604T DE 602006013604 D1 DE602006013604 D1 DE 602006013604D1
- Authority
- DE
- Germany
- Prior art keywords
- patient
- chk1 inhibitors
- determining responsiveness
- chk1
- responsiveness against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65413105P | 2005-02-18 | 2005-02-18 | |
PCT/GB2006/000548 WO2006087557A1 (en) | 2005-02-18 | 2006-02-16 | METHOD FOR DETERMINING RESPONSIVENESS TO CHKl INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006013604D1 true DE602006013604D1 (de) | 2010-05-27 |
Family
ID=36295309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006013604T Active DE602006013604D1 (de) | 2005-02-18 | 2006-02-16 | Verfahren zur bestimmung der reaktionsfähigkeit gegenüber chk1-inhibitoren |
Country Status (24)
Country | Link |
---|---|
US (1) | US20080145358A1 (de) |
EP (1) | EP1853721B1 (de) |
JP (1) | JP2008530575A (de) |
KR (1) | KR20070107034A (de) |
CN (1) | CN101120096A (de) |
AT (1) | ATE464395T1 (de) |
AU (1) | AU2006215413B2 (de) |
BR (1) | BRPI0607798A2 (de) |
CA (1) | CA2598185A1 (de) |
CY (1) | CY1110076T1 (de) |
DE (1) | DE602006013604D1 (de) |
DK (1) | DK1853721T3 (de) |
ES (1) | ES2341796T3 (de) |
HK (1) | HK1113059A1 (de) |
HR (1) | HRP20100313T1 (de) |
IL (1) | IL184873A0 (de) |
MX (1) | MX2007010073A (de) |
NO (1) | NO20074610L (de) |
NZ (1) | NZ556718A (de) |
PL (1) | PL1853721T3 (de) |
PT (1) | PT1853721E (de) |
SI (1) | SI1853721T1 (de) |
WO (1) | WO2006087557A1 (de) |
ZA (1) | ZA200706670B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009005381A (es) * | 2006-11-21 | 2009-06-30 | Merial Ltd | Vacuna para leishmania canina. |
US8263329B2 (en) | 2007-03-29 | 2012-09-11 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer |
US8173366B2 (en) | 2007-03-29 | 2012-05-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer |
GB0720113D0 (en) * | 2007-10-15 | 2007-11-28 | Cambridge Cancer Diagnostics L | Diagnostic, prognostic and predictive testing for cancer |
JP5436786B2 (ja) * | 2008-03-06 | 2014-03-05 | オリンパス株式会社 | 細胞周期計測方法 |
WO2010076887A1 (en) * | 2009-01-05 | 2010-07-08 | Banyu Pharmaceutical Co.,Ltd. | Predictive biomarkers useful for cancer therapy mediated by a wee1 inhibitor |
WO2016126616A1 (en) | 2015-02-02 | 2016-08-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and kits for measuring and quantifying dna double-stranded breaks using gamma-h2ax and h2ax |
EP3452936A4 (de) * | 2016-05-05 | 2020-01-15 | Nantomics, LLC | Checkpoint-fehler und verfahren dafür |
JPWO2018030547A1 (ja) * | 2016-08-12 | 2019-06-13 | 日立化成株式会社 | 血中循環癌細胞の検出方法及び血中循環癌細胞を検出するための前処理方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001161398A (ja) * | 1999-12-06 | 2001-06-19 | Igaku Seibutsugaku Kenkyusho:Kk | タンパク質リン酸化酵素の活性測定方法およびタンパク質リン酸化酵素の活性測定キット |
EP1947102A1 (de) * | 2003-01-09 | 2008-07-23 | Pfizer, Inc. | Zusammensetzungen, enthaltend Diazepinoindol-Derivate als Kinase-Inhibitoren |
MXPA05009885A (es) * | 2003-03-14 | 2005-12-05 | Astrazeneca Ab | Nuevas triazolonas fusionadas y los usos de las mismas. |
EP2669377A3 (de) * | 2003-04-17 | 2015-10-14 | Alnylam Pharmaceuticals Inc. | Modifizierte iRNA-Wirkstoffe |
ITMI20030821A1 (it) * | 2003-04-18 | 2004-10-19 | Internat Ct For Genetic En Gineering And | Polipeptidi chimerici e loro uso. |
US20050207998A1 (en) * | 2003-07-21 | 2005-09-22 | Yaoping Lu | Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer |
AU2004274013A1 (en) * | 2003-09-17 | 2005-03-31 | Icos Corporation | Use of Chk1 inhibitors to control cell proliferation |
-
2006
- 2006-02-16 SI SI200630659T patent/SI1853721T1/sl unknown
- 2006-02-16 CA CA002598185A patent/CA2598185A1/en not_active Abandoned
- 2006-02-16 CN CNA2006800052527A patent/CN101120096A/zh active Pending
- 2006-02-16 DK DK06709785.7T patent/DK1853721T3/da active
- 2006-02-16 AT AT06709785T patent/ATE464395T1/de active
- 2006-02-16 WO PCT/GB2006/000548 patent/WO2006087557A1/en active Application Filing
- 2006-02-16 MX MX2007010073A patent/MX2007010073A/es active IP Right Grant
- 2006-02-16 DE DE602006013604T patent/DE602006013604D1/de active Active
- 2006-02-16 BR BRPI0607798-6A patent/BRPI0607798A2/pt not_active IP Right Cessation
- 2006-02-16 JP JP2007555699A patent/JP2008530575A/ja active Pending
- 2006-02-16 AU AU2006215413A patent/AU2006215413B2/en not_active Ceased
- 2006-02-16 EP EP06709785A patent/EP1853721B1/de active Active
- 2006-02-16 PL PL06709785T patent/PL1853721T3/pl unknown
- 2006-02-16 NZ NZ556718A patent/NZ556718A/en not_active IP Right Cessation
- 2006-02-16 PT PT06709785T patent/PT1853721E/pt unknown
- 2006-02-16 KR KR1020077018373A patent/KR20070107034A/ko not_active Application Discontinuation
- 2006-02-16 ES ES06709785T patent/ES2341796T3/es active Active
- 2006-02-16 US US11/816,128 patent/US20080145358A1/en not_active Abandoned
-
2007
- 2007-07-26 IL IL184873A patent/IL184873A0/en unknown
- 2007-08-10 ZA ZA200706670A patent/ZA200706670B/xx unknown
- 2007-09-11 NO NO20074610A patent/NO20074610L/no not_active Application Discontinuation
-
2008
- 2008-03-03 HK HK08102350.2A patent/HK1113059A1/xx not_active IP Right Cessation
-
2010
- 2010-05-31 HR HR20100313T patent/HRP20100313T1/hr unknown
- 2010-06-09 CY CY20101100544T patent/CY1110076T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1853721T3 (da) | 2010-06-14 |
EP1853721B1 (de) | 2010-04-14 |
HRP20100313T1 (hr) | 2010-07-31 |
CA2598185A1 (en) | 2006-08-24 |
IL184873A0 (en) | 2007-12-03 |
CY1110076T1 (el) | 2015-01-14 |
KR20070107034A (ko) | 2007-11-06 |
ZA200706670B (en) | 2008-10-29 |
MX2007010073A (es) | 2007-10-10 |
ES2341796T3 (es) | 2010-06-28 |
EP1853721A1 (de) | 2007-11-14 |
AU2006215413B2 (en) | 2010-10-07 |
ATE464395T1 (de) | 2010-04-15 |
NZ556718A (en) | 2010-10-29 |
HK1113059A1 (en) | 2008-09-19 |
AU2006215413A1 (en) | 2006-08-24 |
PL1853721T3 (pl) | 2010-08-31 |
US20080145358A1 (en) | 2008-06-19 |
SI1853721T1 (sl) | 2010-06-30 |
CN101120096A (zh) | 2008-02-06 |
JP2008530575A (ja) | 2008-08-07 |
PT1853721E (pt) | 2010-06-08 |
BRPI0607798A2 (pt) | 2010-06-22 |
NO20074610L (no) | 2007-11-14 |
WO2006087557A1 (en) | 2006-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006013604D1 (de) | Verfahren zur bestimmung der reaktionsfähigkeit gegenüber chk1-inhibitoren | |
NO20074389L (no) | Bestemmelse av respondere til kjemoterapi | |
ATE537450T1 (de) | Igfbp2-biomarker | |
ATE438853T1 (de) | Diagnostische testvorrichtung | |
WO2008021290A3 (en) | Organ-specific proteins and methods of their use | |
WO2008054827A3 (en) | Bruton's tyrosine kinase activity probe and method of using | |
DE602006016589D1 (de) | Neue markierungsstrategien für den empfindlichen nachweis von analyten | |
EA200901313A1 (ru) | Ингибиторы тирозинкиназы брутона | |
DE602005012481D1 (de) | 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck | |
ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
DE602005016800D1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
WO2008073177A3 (en) | Expression profiles associated with irinotecan treatment | |
DE602007010246D1 (de) | Verfahren zur blutgerinnungsbestimmung | |
BRPI0515794A (pt) | processos para avaliar pacientes com leucemia mielóide aguda | |
DE602006020706D1 (de) | Verfahren und einrichtung zur hochauflösenden richtungsfindung willkürlicher gerader ordnung | |
ATE475098T1 (de) | Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 | |
MX2009001070A (es) | Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma. | |
IL181192A0 (en) | Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents | |
ATE333521T1 (de) | Detektion von vancomycin-resistenten enterococcus-subspezies | |
ATE537191T1 (de) | Protein, verfahren zur proteinimmobilisierung, struktur, biosensor, nukleinsäure, vektor und kit für den nachweis einer zielsubstanz | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
DE602006015221D1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
DE112005002199A5 (de) | Verfahren und System zur Echtheitsbestimmung der individual-typischen Merkmale von Prüfobjekten | |
DE112008000493A5 (de) | Verfahren und Vorrichtung zur Ultraschall-Messung von Blutfluß | |
DE502005008406D1 (de) | Biosensor und verfahren zu dessen betrieb |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |